EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion. - Farabegoli, Fulvia; Govoni, Marzia; Spisni, Enzo; Papi, Alessio (Bioscience Reports, 2017)